Search Results - "Breast cancer prognosis"

Analysis of knowledge, attitudes and practices regarding breast self-examination among female healthcare workers in Northern India.

Authors: Pandey, Laxman Pandey, Ankita Sathyanarayanan, Margasagaya ShivKumaran et al.

Source: Discover Public Health. 6/21/2026, Vol. 23 Issue 1, p1-11. 11p.

Clinical Characteristics and Prognostic Risk Factors in Breast Cancer With Liver Metastasis.

Authors: Yu, Dandan Zhu, Chengjun Yang, Sujin et al.

Source: Breast Journal. 6/20/2026, Vol. 2026, p1-12. 12p.

The Role of Oncology Nurses in National Breast and Cervical Cancer Screening Programs.

Authors: Brown, Christin McNally, Gretchen A.

Source: Clinical Journal of Oncology Nursing. Jun2026, Vol. 30 Issue 3, p231-235. 5p.

Development and Validation of a Cuproptosis‐Based Risk Score Model for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer: A Transcriptomic Analysis.

Authors: Zhang, Lihai Wang, Jiao Tan, Baihong et al.

Source: Breast Journal. 5/29/2026, Vol. 2026, p1-19. 19p.

Akkermansia muciniphila–Driven ceRNA Networks Regulate Immune Modulation and Breast Cancer Progression.

Authors: Chaudhary, Uma A. S., Arya A., Mythili et al.

Source: Breast Journal. 5/26/2026, Vol. 2026, p1-21. 21p.

Construction of a Lysine Lactylation- and DNA Damage Repair-Related Gene Signature to Predict the Prognosis and Drug Sensitivity of Breast Cancer Patients.

Authors: Zhu, Liang Yuan, Chenwei Li, Yaorong et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4493. 24p.

Clinicopathological Characteristics, Prognosis, and Survival of HER2-Low Breast Cancer Patients Based on a Retrospective Cohort Study of 14,642 Patients.

Authors: Sun, Wantong Hou, Xinyu Yang, Zihan et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1637. 15p.

Therapeutically Engineering Exosomes to Target CD206+ M2 Macrophages to Prevent the Development of Primary Tumors and Distal Metastases in Breast Cancers.

Authors: Parvin, Mahrima Alptekin, Ahmet Kashif, Sawaiz et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1619. 29p.

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation.

Authors: Eiamprapaporn, Panuch Venegas Mata, Cindy Nandani, Raj et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1588. 15p.

Chemotherapeutics as Immune Modulators for the Treatment of Triple-Negative Breast Cancer.

Authors: Fines, Cory B. Kelly, Sorcha McCarthy, Helen O. et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1537. 17p.

Integrative Survival Prediction in Breast Cancer Using Extracellular Matrix Protease Transcript Signatures and Clinical Variables: A Machine Learning Approach.

Authors: Babas, Rami Vynios, Demitrios H. Kompothrekas, Aristotelis et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1497. 23p.

PD-L1-Guided Chemo-Immunotherapy in Advanced Triple-Negative Breast Cancer: A Meta-Analysis of Survival Benefits and Toxicity Profiles.

Authors: Nan, Lingshan Zuo, Xi Yin, Xiaohui et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1352. 16p.

NFYA-Mediated TTK Up-Regulation Drives Fast Cell Cycle Progression and Its Inhibition Leads to Mitotic Catastrophe in Triple Negative Breast Cancer.

Authors: Liu, Nianqiu Zhu, Mengdi Cai, Zijie et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1324. 20p.

Movement Disorders Associated With Breast Cancer: A Systematic Review.

Authors: Garg, Ravindra K Jain, Amita Agrawal, Akshay A et al.

Source: Annals of Indian Academy of Neurology. May/Jun2026, Vol. 29 Issue 3, p336-342. 7p.

Integrin Beta 4 Protein Expression Bimodally Predicts Sensitivity to CDK4/6 Inhibition and Resistance to Immunotherapy in Breast Cancer.

Authors: Zhu, Zhi-Min Hu, Lei Ma, Yan-Wen et al.

Source: Breast Journal. 4/22/2026, Vol. 2026, p1-14. 14p.

Radiomic signatures associated with longitudinal TNM downstaging for prognostic stratification in breast cancer.

Authors: Fan, Ming Liu, Weihao Zhao, Bohan et al.

Source: Insights into Imaging. 4/18/2026, Vol. 17 Issue 1, p1-14. 14p.

Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase) Inhibitors: A Single-Institution Experience †.

Authors: Akkoc Mustafayev, Fatma Nihan Fountzilas, Elena Munsell, Mark F. et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1258. 16p.

Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab.

Authors: Ambicka, Aleksandra Grela-Wojewoda, Aleksandra Niemiec, Joanna et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1243. 18p.

Gene-Specific Outcomes After Central Nervous System Metastases in Germline BRCA1- and BRCA2-Associated Breast Cancer.

Authors: Decaminada, Alice Sunder-Plassmann, Raute Ho, Weang-Kee et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1240. 15p.

Modifying Epigenetic Landscapes to Restore Immune Therapeutic Responses in Triple Negative Breast Cancer.

Authors: Almalki, Nabeelah Vázquez-Cantú, Mercedes Thomas, Riba et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1221. 19p.